Browsing Category

24412 posts

AI-for-Science Startup ChemLex Raises USD 45M, Launching Self-Driving Lab for Drug Discovery in Singapore

SINGAPORE, Dec. 8, 2025 /PRNewswire/ — ChemLex, a next-generation AI-for-science company, today…

ProstACT Global Phase 3 Update: First Patient Dosed in Randomized Treatment Expansion, Part 1 Readout Plans Confirmed

MELBOURNE, Australia and INDIANAPOLIS, Dec. 8, 2025 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX:…
The 4th China International Supply Chain Expo Set for Beijing in June 2026

The 4th China International Supply Chain Expo Set for Beijing in June 2026

Sustained Worldwide Outreach Drives Greater Collaboration Opportunities BEIJING, Dec. 7, 2025 /PRNewswire/…
How is Thailand addressing health risks from smog?

How is Thailand addressing health risks from smog?

Thailand is implementing a multi-faceted response to health risks from smog, especially…
CARsgen's CAR-T Product Zevor-Cel Included in China's Commercial Health Insurance Innovative Drug Catalogue

CARsgen's CAR-T Product Zevor-Cel Included in China's Commercial Health Insurance Innovative Drug Catalogue

SHANGHAI, Dec. 7, 2025 /PRNewswire/ — CARsgen Therapeutics Holdings Limited (Stock Code:…

All Approved Indications of Five Akeso's Innovative Drugs Included in China's Latest NRDL: Featuring Two First-in-Class Bispecifics with New First-Line Indications and Three Newly Negotiated Drugs

HONG KONG, Dec. 7, 2025 /PRNewswire/ — Akeso, Inc. (9926.HK) ("Akeso" or…

Skymizerʼs HyperThought™ Wins "Best IP/Processor of the Yearˮ and "Most Promising Productˮ at EE Awards Asia 2025

TAIPEI, Dec. 7, 2025 /PRNewswire/ — Skymizer today announced that its next-generation…

Innovent Announces Inclusion of Seven Innovative Drugs including TYVYT New Indication and SYCUME in China's National Reimbursement Drug List

SAN FRANCISCO and SUZHOU, China, Dec. 7, 2025 /PRNewswire/ — Innovent Biologics, Inc. ("Innovent")…